Research
Paper Design Plan and Topic Proposal
After doing, the
photo essay I realize that I am not interested enough in exoplanets to do a
whole paper on it. I do have a desire to know more about health related
subjects so this paper I really want to focus on something that I have a
passion for and that’s medicine mainly cancer. I know there are so many
different types of cancers that it is hard to keep track of and though I know,
we have made major improvements in treating patients. There are still some
forms that do not have a very good prognosis and that are what I want to learn
about. I have a basic knowledge of cancer which I think any person would know
but I want to get an in depth knowledge of some types of brain cancers,
melanoma, and pancreatic cancers. I know that many of these can be very lethal
and I would love to see what new advances are being made to help patients with
these forms.
My
strategy for this research paper is to find data on past treatments and present
treatment that doctors are using to treat these forms of cancer and to find
innovations or improvements that might be on the way in the near future. I want
to find pictures of what each form of cancer looks like I also want to get
graphs with survival rates comparing the survival rates of these forms of
cancer verses other forms that have a better prognosis. I want the graphs to
show that there is a big difference in survival when it comes to these types of
cancers. I would also like to get some information and pictures of the type of
tests and treatments that they administer to patients. The arrangement of the
paper will be a series of pictures, graphs, and other statistics concerning
these various forms of cancer. I will be producing this research paper in paper
form and it will be uploaded to my blog.
The
argument that I hope to make is to give people hope. I want to find that there
are advances being made to help cure these cancers or at least give patients a
fighting chance. No person should ever have to experience being given a death
sentence like the one my grandmother did. I want to figure out why these forms
are so deadly and hard to treat and what is and can be done about it.
I
would imagine people would agree everywhere you go you will always find at
least one person who has been touched and affected by cancer. I could not
imagine anyone not thinking that this argument and research is not worth doing.
The
only thing I know about the topic is that these forms of cancer can be very
hard to treat. In addition, some forms of these cancers can have a terrible
prognosis from the start. Cancers are mutations in our body that happen over
time some are worse and more inconspicuous then others that that can make them
harder to find and treat. I know there is not a lot of information about brain
cancer because the brain is such a sensitive structure and you cannot get in
the brain many times to achieve that type of research. I know that melanoma if
caught early has a good prognosis but if it metastasizes, those rates drop
dramatically.
I
plan to conduct this research by speaking to a few oncologists and get a better
idea on how they treat and approach these forms of cancers. I plan to get some
information from the National Cancer Institute as well as some diagnostic
journals. I want to make sure I can find sources that have the various stages
and what changes in prognosis does metastasize present.
After
this research, I hope on getting more peace of mind when it comes to cancer. I
hope to work in the field of oncology so I want to know all I can possibly find
about the subject. The more I know the more I can help. I do not want people to
ever have to experience losing a loved or being diagnosed with a disease like
cancer. Since I know that day is far away I want to give as much hope to the
ones that have to deal with it.
Fatal Cancers
Cancer is a disease caused by
mutations that causes cells to overgrow uncontrollably and to perform
abnormally. The prognosis for cancer patients have improved significantly over
the years due to new treatments as well as better techniques. However, when it
concerns some forms mainly pancreatic, melanoma, and malignant gliomas there
has not been the significant improvement in prognosis and survival rate. There
needs to be a remarkable improvement with these forms of cancer if people are
ever going to have hope of beating these horrible diseases. These forms of
cancer have poor survival rates either because they are not diagnosed early
enough , and are very aggressive forms that in most cases spread quickly, which
can be resistant to treatment as well as doctors not having the research as
well as techniques to solve some of the main issues that these diseases
possess. Even though the prognosis will change with any form of cancer when you
have metastases, the prognosis drops significantly with these forms unlike some
others. In some cases, the treatments can also cause many complications in
addition to the cancer itself. The research in these forms is in dire need for
new information as well as new treatments. There needs to be better screening
and testing so that some of these people can catch the cancer early enough to
intervene before It becomes too late so that the treatment and surgery are
still options for them. I also believe that there are some decisions that have
been made that do not help the patient prolong life no matter what the
prognosis may be.
Melanoma is a very
aggressive skin cancer caused by melanocytes. Melanocytes are responsible for
making melanin, which gives the color to our skin. Melanoma is a form of cancer
that still needs to see a major improvement in survival rate and treatment. The
researchers at the New England Medical Journal
have discovered although melanoma only accounts for 4 percent of skin cancers
melanoma accounts for 80 percent of skin cancer deaths and once this cancer
metastasizes, only 4 percent of patients actually survive 5 years (New England Journal
of Medicine 2006). Which shows how
disproportional the mortality rate is compared to the actual number of cases. When
a cancer metastasizes it spreads to other parts of the body which, changes the
prognosis dramatically especially with this type of cancer. The biggest hurdle
is that doctors and researches still have a lot to learn and there remain many
unknowns about this disease, its treatments, and the mechanisms of the disease
and why it spreads so aggressively. What they have found through research is
one of the biggest risk factors for this cancer is familial history along with
atypical nevi or moles and a history of melanoma in the past (New England Journal
of Medicine 2006). The immunosuppressed and people exposed to UV radiation also
pose a risk. It is important to use sunblock while in the sun because if you
are sunburned as children often and as an adult now use sunscreen you are still
very much a risk for melanoma due to a history of sunburn. In 2006, a discovery
found that tanning regularly before the age of 35 can increase ones risk of
melanoma by 87 percent. The key to improving the survival rate of this type of
cancer is early awareness and becoming knowledgeable of the risk factors as
well as taking the necessary precautions to keep your risk levels low. People should
follow the ABCDE’s when examining the body (Journal of American Medicine 2011).
The “A” represents asymmetry, which means if cut in half each side looks
different. The next characteristic a
mole should have is a smooth border it should not be irregular and jagged. A
mole should have consistent color throughout and should not be two toned; the
diameter for the mole should be no more than a pencil eraser and you should
watch for an evolution and elevation of your mole. Any of these signs can be
the beginning stages of melanoma. Even though it might present as just an
abnormal mole the cancer is spreading and penetrating far below the surface of
the skin to your blood, lymph nodes, and to other organs as well. What worries
me the most about this cancer is it can spread from a small mole to the rest of
your body. You might not even see or notice the mole or patch of skin until it
is too late. The type of metastases
affects the prognosis of the patient as well. The Lancet Journal expounds on The
New England Medical Journal’s data by describing the estimated survival
rates on specific forms of metastases. When the patient has distant metastases,
where it spreads to distant organs far from the origin the survival time is
only about 6 to 9 months (Clinical and Experimental Dermatology 2000). Whereas
if it spreads to the brain, bone, or liver you only have about 3 to 4 months
(Clinical and Experimental Dermatology 2000). The only prognosis, which has a
slightly higher survival time, is metastasize to lymph nodes, which gives you
about 12 to 15 months (Clinical and Experimental Dermatology 2000). If caught
very early, melanoma can be treated. The issue is the majority of cases are
already advanced and present with metastases through the body, which causes complications.
Unfortunately, doctors and researchers still do not understand why melanoma is
so resistant to chemotherapy, which is one of the reasons why it is so deadly. In
addition, as explained patients do not have very long to live and therefore, do
not have the time to try different techniques and treatments that could improve
prognosis, which is another issue. However, the researchers in the department
of dermatology in Wurzburg, Germany have seen some promising results from
immuno-modularly techniques (Clinical and Experimental Dermatology 2000).
Immuno-modulary techniques use the body’s own defenses like antibody’s and
white blood cells from either a donor or the patient to fight the cancer rather
than using only radiation and chemotherapy, which is helpful because even
though chemotherapy kills cancerous cells it also kills healthy cells.
Immuno-modulary does not have the risks of chemotherapy because it is specific
and will only kill the cancerous cells. However, these treatments have not been
used in a large enough group of patients to see how much of an improvement the
treatment is making. This type of therapy has been used for other types of
cancers as well with more definite results.
![]() |
| Figure 1 Aymmetry |
![]() |
| Figure 2 Border |
![]() |
| Figure 3 Color |
![]() |
| Figure 4 Size |
![]() |
| Figure 5 Evolution |
Even though
mortality rates for most cancers are on the decline pancreatic cancer deaths
are rising. Pancreatic cancer is the fourth leading cause of cancer deaths.
Which leads me to believe that not enough progress has been made with this form
of cancer as well. This form of cancer
is classified depending on where the cancer is. The exocrine part of the
pancreas is responsible for making digestive substances and the endocrine is
responsible for insulin and other hormones. The endocrine part of the pancreas
makes up about 95 percent of the pancreas (The Lancet Journal 2011). Therefore,
most pancreatic cancers arise here. A major issue with pancreatic cancer is it
has an insidious onset and there are either no symptoms or benign symptoms,
which could be as simple as back pain. Symptoms usually do not arise until the
cancer is already in the advanced stages and has spread. The discovery of this
cancer once it is advanced is true in 80-85 percent of patients (The Lancet
Journal 2011). Only about 4 percent of people with pancreatic cancer will live
5 years. A survival rate of 4 percent for cancer is rare with most other forms.
Even though so much progress has been made as well as new techniques developing
over the years to increase, survival rates of cancer these few forms remain
very low. The most significant risk factors for this disease are family history
and smoking. Cigarette smoking accounts for 20 percent of pancreatic tumors
(The Lancet Journal 2011). This occurs because smokers with cancers have more
mutations rather than a non-smoker (The Lancet Journal 2011).
![]() |
| Pancreas with Tumors |
Another
significant drawback to this cancer is that people as well as clinicians do not
pay attention to the fact that familial history can play a huge role in this
cancer. The use of this information could save lives. Therefore knowing your
family history is an essential tool in assessing your health as well as risks.
If
someone is able to recognize they have a familial risk they can undergo
genetic testing and cancer screenings to help assess the risk and maybe catch a
mutation early. This is one of the only ways that the disease can be prevented
from becoming fatal is the early detection or prevention by testing, healthy
diet and by not or to quit smoking. However, as the facts and survival rates
show this screening and use of familial history are not utilized enough.
Another issue with this disease is that it is not very susceptible to
chemotherapy. In most cases adjuvant therapy is used,
which consists of chemotherapy given after surgery, which can help manage the
disease. Unfortunately, with this cancer, treatment only prolongs and makes
life more comfortable. Curing the cancer is not the goal as it is unrealistic.
When patients enter the advanced stages of the disease, the main treatment is
palliative care rather than curative. Palliative care is treatment only used to
treat pain and discomfort. When most patients reach the advanced stages,
sometimes the cancer leaves them too weak and immune compromised to the point
where they cannot even use the treatment, as it would cause more damage than
good (The Nurse Practitioner 2010). From personal experience, I have never seen
a cancer as aggressive as pancreatic. When it happen with my grandmother like
most other cases her symptoms were benign and did not cause much alarm until
the late stages. Unfortunately, by that time there was not much they could do
because of the advanced nature. As well as the ineffectiveness of chemotherapy.
It took less than a month from diagnosis to the time she passed away. Sadly,
this is the story for many patients that suffer from pancreatic cancer.
Brain cancer specifically malignant gliomas are forms of cancer that are far behind as well when it concerns the treatment and prognosis of patients. Malignant gliomas are very invasive tumors and are only considered malignant when they are in Stages 3 and 4 of the disease. The main issue is that this cancer is rare and has an abnormally high mortality rate. Therefore, people have a median survival rate of only 1 to 2 years. A main problem that lead investigator Susan Chang M.D. saw is that only 700 patients were in clinical trials to receive new or upcoming treatments and even though there is, a plethora of research that indicates chemotherapy prolongs life, only 54 percent of patients are prescribed it by his or her oncologist (The Journal of the National Cancer Institute 2005). That is a major issue is that treatment for this cancer has not been consistent so much so that 54 percent of patients are going without treatment. It should not matter how bad a prognosis is you should always give a patient any treatment possible to prolong life. A main issue with this cancer is that it is reoccurring. Reoccurring malignant gliomas will grow back even after every cancerous part of the tumor has been taken out so much so that it occurs 90 percent of the time (New England Journal of Medicine 2008). Even though cancer can be somewhat resistant to therapy, it has many side effects that include cognitive dysfunction, deep vein blood clots, seizures and fluid retention around the tumor (New England Journal of Medicine 2008). Some of the side effects alone could be life threatening. This problem was also outlined in The Clinical Journal of Oncology where researchers found a lot of patients are not made aware of the extent these complications can affect your life during and after treatment mainly the cognitive difficulties (Clinical Journal of Oncology Nursing 2009). This is a main issue in my opinion even though patients are only concerned about treatment and prolonging their life they should always be made aware of the risks and complications associated with treatment. It is a responsibility of the doctor to inform a patient of all information fully and clearly. Treatment for this cancer is difficult as well for the very reason that it can be resistant to chemotherapy so instead they use radiation therapy. However once again it does not treat the cancer it can only prolong life and since the cancer reoccurs 90 percent of the time increasing the radiation does not help or deter that from happening (New England Journal of Medicine 2006). As well as at some point surgery is no longer an option because the tumor has become so invasive and has spread so far that it becomes inoperable due to the sensitivity of the brain. My opinion on the fact that this cancer is far behind in terms of improvement was shared by Bernadine Donahue M.D. which said through research they have found that this cancer is in the same place breast cancer was 15-20 years ago (Journal of the National Cancer Institute 2005 ). The low prognosis along with the aggressiveness and difficulties with treatment make this a very difficult form of cancer to overcome.
Brain cancer specifically malignant gliomas are forms of cancer that are far behind as well when it concerns the treatment and prognosis of patients. Malignant gliomas are very invasive tumors and are only considered malignant when they are in Stages 3 and 4 of the disease. The main issue is that this cancer is rare and has an abnormally high mortality rate. Therefore, people have a median survival rate of only 1 to 2 years. A main problem that lead investigator Susan Chang M.D. saw is that only 700 patients were in clinical trials to receive new or upcoming treatments and even though there is, a plethora of research that indicates chemotherapy prolongs life, only 54 percent of patients are prescribed it by his or her oncologist (The Journal of the National Cancer Institute 2005). That is a major issue is that treatment for this cancer has not been consistent so much so that 54 percent of patients are going without treatment. It should not matter how bad a prognosis is you should always give a patient any treatment possible to prolong life. A main issue with this cancer is that it is reoccurring. Reoccurring malignant gliomas will grow back even after every cancerous part of the tumor has been taken out so much so that it occurs 90 percent of the time (New England Journal of Medicine 2008). Even though cancer can be somewhat resistant to therapy, it has many side effects that include cognitive dysfunction, deep vein blood clots, seizures and fluid retention around the tumor (New England Journal of Medicine 2008). Some of the side effects alone could be life threatening. This problem was also outlined in The Clinical Journal of Oncology where researchers found a lot of patients are not made aware of the extent these complications can affect your life during and after treatment mainly the cognitive difficulties (Clinical Journal of Oncology Nursing 2009). This is a main issue in my opinion even though patients are only concerned about treatment and prolonging their life they should always be made aware of the risks and complications associated with treatment. It is a responsibility of the doctor to inform a patient of all information fully and clearly. Treatment for this cancer is difficult as well for the very reason that it can be resistant to chemotherapy so instead they use radiation therapy. However once again it does not treat the cancer it can only prolong life and since the cancer reoccurs 90 percent of the time increasing the radiation does not help or deter that from happening (New England Journal of Medicine 2006). As well as at some point surgery is no longer an option because the tumor has become so invasive and has spread so far that it becomes inoperable due to the sensitivity of the brain. My opinion on the fact that this cancer is far behind in terms of improvement was shared by Bernadine Donahue M.D. which said through research they have found that this cancer is in the same place breast cancer was 15-20 years ago (Journal of the National Cancer Institute 2005 ). The low prognosis along with the aggressiveness and difficulties with treatment make this a very difficult form of cancer to overcome.
Figure 7Fatal Malignant Glioma
Cancer
is a horrible disease that researchers and doctors have been working hard to
try to overcome. Yet these forms have fallen far behind when it comes to the
options people have to prolong their life. No one should have to deal with
having a death sentence when it comes to any disease. Some mistakes made by
doctors regarding treatment as well as not assessing familial history properly are
not helping people have a better chance at surviving. There is also a
responsibility on the patient to check for signs and to be checked regularly if
they see something that looks abnormal, they must get it looked at as it could
save his or her life. It is going to take a combination of vigilance on the end
of researchers and doctors as well as people themselves to make the changes
that need to happen in these diseases because not enough progress as it stands
now. However, the sad fact remains that the research and prognosis of these
forms of cancer are far behind the times and unfortunately, more people will
succumb to these diseases before it gets better.
References
Miller,
Arlo J, M.D., PhD. and Mihm, Martin C, Jr, M.D. Mechanisms of Disease:
Melanoma." The New England Journal of Medicine 355.1 (2006): 51-65.
ProQuest. Web. 3 Apr. 2014.
Vincent,
Audrey, et al. "Pancreatic Cancer." The Lancet 378.9791
(2011): 607-20. ProQuest. Web. 3 Apr. 2014.
Evens, K, and VS Eschiti.
"Cognitive Effects Of Cancer Treatment: "Chemo Brain"
Explained." Clinical Journal Of Oncology Nursing 13.6 (2009): 661-666.
CINAHL Complete. Web. 7 Apr. 2014.
Sun,
Virginia. "Update on Pancreatic Cancer Treatment." The Nurse
practitioner 35.8 (2010): 16-22. Print.
Brower,
Vicki. "Large Variations seen in Treatment of Adults with Brain
Cancer." The Journal of the
National Cancer Institute, sec. 97: 478. 2005. Print.
Pluta, Ryszard M, M.D., PhD. & Burke, A. E., M.A.
(2011). Melanoma. JAMA, 305(22), 2368.
Becker,
J C, E Kämpgen, and E Bröcker. "Classical Chemotherapy for Metastatic
Melanoma." Clinical and Experimental Dermatology 25.6 (2000):
503-508. MEDLINE Complete. Web. 15 Apr. 2014.
Wen,
Patrick Y., M.D., and Kesari, Santosh, M.D., PhD. "Medical Progress:
Malignant Gliomas in Adults." The New England journal of medicine
359.5 (2008): 492-507. ProQuest. Web. 30 Apr. 2014.
"Asymmetry".
Photograph. Skin Cancer. Web. 28 Apr. 2014.
http://www.skincancer.org/skin-cancer-information/melanoma.
---.”Border”
---.”Color”
---.”Size”
---.”Evolution”
"Pancreas
with Tumors". Photograph. Wikipedia. Web. 28 Apr. 2014.
http://en.wikipedia.org/wiki/Pancreatic_cancer.
"Fatal
Malignant Glioma". Photograph. Web. 28 Apr. 2014.
https://lookfordiagnosis.com/mesh_info.php?term=glioblastoma&lang=1.







No comments:
Post a Comment